-
61
Glucose‐induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinoma
Published 2024-12-01“…Clinical and Translational Medicine…”
Get full text
Article -
62
CMPK2 promotes NLRP3 inflammasome activation via mtDNA‐STING pathway in house dust mite‐induced allergic rhinitis
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article -
63
Erratum for the research article “The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super‐enhancer activity and the PI3K/AKT/mTOR signalling...
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article -
64
Machine learning‐based multi‐omics models for diagnostic classification and risk stratification in diabetic kidney disease
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article -
65
LRH‐1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype
Published 2024-12-01“…Clinical and Translational Medicine…”
Get full text
Article -
66
PINK1 modulates Prdx2 to reduce lipotoxicity‐induced apoptosis and attenuate cardiac dysfunction in heart failure mice with a preserved ejection fraction
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article -
67
Single‐cell sequencing analysis reveals cetuximab resistance mechanism and salvage strategy in colorectal cancer
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article -
68
New pathogen for gastric cancer: Streptococcus anginosus
Published 2024-12-01“…Clinical and Translational Medicine…”
Get full text
Article -
69
Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
Published 2024-12-01“…Clinical and Translational Medicine…”
Get full text
Article -
70
Integrating multi‐omics features enables non‐invasive early diagnosis and treatment response prediction of diffuse large B‐cell lymphoma
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article -
71
Titin gene mutations enhance radiotherapy efficacy via modulation of tumour immune microenvironment in rectum adenocarcinoma
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article -
72
The role of the interplay between macrophage glycolytic reprogramming and NLRP3 inflammasome activation in acute lung injury/acute respiratory distress syndrome
Published 2024-12-01“…Clinical and Translational Medicine…”
Get full text
Article -
73
The role of acetylation and deacetylation in cancer metabolism
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article -
74
The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article -
75
Epithelial NSD2 maintains FMO‐mediated taurine biosynthesis to prevent intestinal barrier disruption
Published 2024-12-01“…Clinical and Translational Medicine…”
Get full text
Article -
76
Investigating intra‐tumoural heterogeneity and microenvironment diversity in primary cardiac angiosarcoma through single‐cell RNA sequencing
Published 2024-12-01“…Clinical and Translational Medicine…”
Get full text
Article -
77
The antiarthritic effect of CBR‐470‐1 in hypoxic environment is to increase the level of NOD‐like receptor family pyrin domain containing 3 ubiquitination by decreasing phosphoglyc...
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article -
78
The future of G protein‐coupled receptor therapeutics: Apelin receptor acts as a prototype for the advancement of precision drug design
Published 2024-12-01“…Clinical and Translational Medicine…”
Get full text
Article -
79
Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGF...
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article -
80
RECQL4 affects MHC class II‐mediated signalling and favours an immune‐evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melan...
Published 2025-01-01“…Clinical and Translational Medicine…”
Get full text
Article